Oregon Public Employees Retirement Fund Acquires 9,985 Shares of Intuitive Surgical, Inc. $ISRG

Oregon Public Employees Retirement Fund raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 40,956 shares of the medical equipment provider’s stock after purchasing an additional 9,985 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Intuitive Surgical were worth $18,317,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Harrell Investment Partners LLC lifted its holdings in shares of Intuitive Surgical by 3.8% in the 3rd quarter. Harrell Investment Partners LLC now owns 1,871 shares of the medical equipment provider’s stock valued at $837,000 after acquiring an additional 68 shares during the last quarter. Duncker Streett & Co. Inc. raised its position in Intuitive Surgical by 2.3% during the third quarter. Duncker Streett & Co. Inc. now owns 4,601 shares of the medical equipment provider’s stock valued at $2,058,000 after purchasing an additional 105 shares during the period. Steigerwald Gordon & Koch Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $153,000. Clear Harbor Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Clear Harbor Asset Management LLC now owns 12,234 shares of the medical equipment provider’s stock worth $5,471,000 after purchasing an additional 165 shares during the period. Finally, WD Rutherford LLC increased its position in shares of Intuitive Surgical by 0.9% during the 3rd quarter. WD Rutherford LLC now owns 8,191 shares of the medical equipment provider’s stock valued at $3,663,000 after purchasing an additional 71 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG stock opened at $585.08 on Friday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm’s 50-day moving average is $564.92 and its 200 day moving average is $511.04. The company has a market capitalization of $209.74 billion, a PE ratio of 77.39, a P/E/G ratio of 4.82 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.84 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 7,562 shares of the stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $193,595.79. This represents a 95.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gary S. Guthart sold 28,800 shares of the firm’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the transaction, the insider owned 27,027 shares in the company, valued at approximately $14,798,904.12. This represents a 51.59% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 114,007 shares of company stock valued at $63,533,844 over the last 90 days. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ISRG shares. The Goldman Sachs Group restated a “buy” rating and issued a $714.00 price target on shares of Intuitive Surgical in a research report on Friday. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Rothschild & Co Redburn lifted their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Citigroup lowered shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $650.00 to $635.00 in a research report on Thursday, December 11th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $622.17.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.